PEP-CTN A Phase 1 study of oral cedazuridine and decitabine combination (ASTX727, IND# TBD, NSC# 820631) and filgrastim as maintenance therapy post-hematopoietic stem cell transplant in children with high-risk acute myeloid leukemia Pediatric CIRB Active Available to Open